Results 21 to 30 of about 983,966 (332)
Mass Drug Administration (MDA) for Schistosomiasis [PDF]
Weisong Wang, Yun‐Kuan Liang
openalex +4 more sources
Mass drug administration for trachoma: how long is not long enough? [PDF]
BACKGROUND:Blinding trachoma is targeted for elimination by 2020 using the SAFE strategy (Surgery, Antibiotics, Facial cleanliness, and Environmental improvements). Annual mass drug administration (MDA) with azithromycin is a cornerstone of this strategy.
Violeta Jimenez+4 more
doaj +5 more sources
Serology for trachoma surveillance after cessation of mass drug administration. [PDF]
BackgroundTrachoma, caused by Chlamydia trachomatis (Ct), is the leading infectious cause of blindness worldwide. Yearly azithromycin mass drug administration (MDA) plays a central role in efforts to eliminate blinding trachoma as a public health problem.
Diana L Martin+13 more
doaj +4 more sources
Mass drug administration for malaria [PDF]
Studies evaluating mass drug administration (MDA) in malarious areas have shown reductions in malaria immediately following the intervention. However, these effects vary by endemicity and are not sustained. Since the 2013 version of this Cochrane Review on this topic, additional studies have been published.Primary objectives To assess the sustained ...
Shah, Monica P+5 more
openaire +3 more sources
Mass drug administration: the importance of synchrony [PDF]
Mass drug administration, a strategy in which all individuals in a population are subject to treatment without individual diagnosis, has been recommended by the World Health Organization for controlling and eliminating several neglected tropical diseases, including trachoma and soil-transmitted helminths.
Daozhou Gao+3 more
openalex +7 more sources
Mass drug administration for malaria [PDF]
Mass drug administration (MDA), defined as the empiric administration of a therapeutic antimalarial regimen to an entire population at the same time, has been a historic component of many malaria control and elimination programmes, but is not currently recommended.
S. Patrick Kachur+6 more
openaire +3 more sources
Mass drug administration of azithromycin: an analysis
WHO recommends mass drug administration (MDA) of the antibiotic azithromycin for children aged 1-11 months in areas with high rates of infant and child mortality. Notwithstanding the substantial potential benefits of lowering childhood mortality, MDA raises understandable concerns about exacerbating antibiotic resistance.In this study, we aimed to ...
Rebecca, Kahn+3 more
openaire +2 more sources
Assessing the impact of a missed mass drug administration in Haiti. [PDF]
Lymphatic filariasis (LF) is a disfiguring and debilitating parasitic disease that is endemic in 81 countries, placing a staggering 1.3 billion people at risk for filarial infection [1]. In 1997, the World Health Assembly resolved to eliminate LF as a public health problem, and in 2000, the Global Programme to Eliminate Lymphatic Filariasis (GPELF) was
Kimberly Y Won+4 more
doaj +5 more sources
Antimalarial mass drug administration: ethical considerations [PDF]
Falciparum malaria is a major cause of death and illness in tropical countries, particularly in childhood. In endemic countries, a significant proportion of the community is infected with malaria asymptomatically. One promising way to eliminate malaria is to give the entire population malaria treatment. This is called mass drug administration (MDA) and
Cheah, PY, White, NJ
openaire +3 more sources
Antimalarial mass drug administration in large populations and the evolution of drug resistance.
Mass drug administration (MDA) with antimalarials has been shown to reduce prevalence and interrupt transmission in small populations, in populations with reliable access to antimalarial drugs, and in populations where sustained improvements in diagnosis
Tran Dang Nguyen+5 more
doaj +1 more source